Overview
It is our intent to support institutions with fellowship programs for gastroenterologists/physicians working in the field of IBD that have a strong organizational focus on diversity, equity, and inclusion and a strong training focus on healthcare equity, clinical practice, research, education, and advancing the standard of care in IBD (i.e., IUS, AI endoscopy, machine learning).
Project Types and Area of Interest
The goal of this RFP is to offer salary support for IBD fellowship programs. It is our intent to support fellowship programs at institutions with clinical training programs in regions where there are continued workforce challenges and that have a strong focus on healthcare equity, clinical practice, research, education, and advancing the standard of care in IBD (i.e., IUS, AI endoscopy, machine learning) to further the understanding of IBD. Programs that prioritize diversity and inclusion principles, focus on health equity initiatives, and address health care disparities and social determinants of health are strongly encouraged. Preference will be given to programs that are located in states underserved by number of IBD fellowships and serving an underserved population. Grants will be awarded based on the strength of the requesting organization’s ability to provide expert mentorship, training, and guidance to the fellow.
Funding Range and Project Length
Grant funding is available to support a one year fellowship up to $80,000 USD.
While Pfizer does not publish a universal scoring rubric, successful applications share several common features, based on how competitive RFPs are structured and how selections are typically made:
1) Strong Alignment With the RFP’s Topic + Unmet Need
Pfizer grant RFPs are narrow: they focus on a detailed research or clinical improvement question (e.g., pneumococcal carriage post-vaccine introduction).
➡️ Success predictor: Your proposal must directly address the specific gap and objectives articulated in the RFP.
2) Clear Relevance to Patient Outcomes or Public Health Impact
Pfizer emphasizes improving patient outcomes in areas of unmet medical need.
➡️ Success predictor: Demonstrate how your project will advance clinical understanding, improve care, or support better health outcomes rather than just adding incremental data.
3) Scientific Merit & Feasibility
Reviewers look for proposals that are:
Well-designed with appropriate methods.
Realistic timelines and achievable objectives.
Relevant preliminary data or rationale showing feasibility.
➡️ Success predictor: A compelling scientific plan that shows the project can be completed within the budget and time.
4) Organizational Capacity
Since grants are usually awarded to organizations (not individuals), institutions must demonstrate:
Ability to execute the project and manage funds.
Administrative and ethical oversight capacity (e.g., IRBs, data management).
➡️ Success predictor: Strong institutional backing and demonstrated project management ability.
5) Patient-Centered and Health Systems Relevance
Many grants (especially in clinical and QI spaces) look for work that will:
Inform clinical practice (e.g., therapy management).
Fill gaps in diagnosis, treatment adherence, or care delivery.
➡️ Success predictor: Projects that connect evidence generation to meaningful practice change or health care improvements are more competitive.
6) Budget Justification & Responsible Use of Funds
Grant proposals must include a realistic, justified budget tied to project activities.
➡️ Success predictor: Budgets that align precisely with what is needed to answer the RFP’s questions — without excess — are favored.
Here’s a quick checklist for competitive Pfizer grant applications:
✔ Extract the exact research or clinical gap the RFP describes.
✔ Frame your aims to directly respond to each RFP objective.
✔ Demonstrate measurable outcomes (e.g., clinical endpoints, educational improvements).
✔ Provide solid scientific or real-world evidence rationale.
✔ Show institutional capability and compliance readiness.
✔ Justify the budget tightly against deliverables.
Pfizer’s research and independent grant portfolio isn’t a general investigator funding source — it’s RFP-driven and strategic, with success heavily reliant on:
Precision fit to the published topic.
Impact on health outcomes and unmet needs.
Scientific rigor and feasibility.
Organizational strength and execution plan
• US-based accredited academic institutions
• Do not include the name of the potential fellow(s) in the application materials. This grant will be awarded to an institution, not an individual.
• Institutions with fellowship programs that include independent research and a strong mentoring program. Clinical training may be included in the program but is not required.
• No aspect of the fellowship program can benefit Pfizer’s business or a Pfizer asset.
• Examples of independent research include: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; use of screening tools and their impact on improvement of patient health.
• Examples of research that would not be eligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.).
• Examples of clinical training include: educational time with an interdisciplinary team in review of case examples and relevant didactic training as well as use of tools for improvement in patient health for specific therapeutic areas or conditions.
• Fellow time spent in the clinical setting that is supported through grant funds must not be billed as patient care.
Eligible Countries:
Sponsor Institute/Organizations: Pfizer
Sponsor Type: Corporate/Non-Profit
Address: 66 Hudson Boulevard East, New York, NY 10001-2192
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Apr 01, 2026
Apr 01, 2026
$80,000
Affiliation: Pfizer
Address: 66 Hudson Boulevard East, New York, NY 10001-2192
Website URL: https://cdn.pfizer.com/pfizercom/2026-02/2026-I%26I-US-GI-Fellowship.pdf?VersionId=078AIjBpC1y2ecrv7LnovLtuDSg5OZpg
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.